Aequs Ltd

Aequs Limited will hold a board meeting on Monday, October 26, 2026, to consider and approve the unaudited financial results, both standalone and consolidated, for the quarter and half year ended September 30, 2026, along with a limited review report from statutory auditors; the company previously closed the trading window for its equity shares from October 1, 2026, until 48 hours after the financial results are declared.

Aequs Limited, formerly known as Aequs Private Limited, submitted a certificate to the National Stock Exchange of India Limited and BSE Limited, issued by KFin Technologies Limited, its Registrar and Share Transfer Agent, for the quarter ended September 30, 2026, in compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018.

Aequs Limited announced that its board approved a preferential issue of up to 28,071,690 warrants, each convertible into one equity share, to Mellwood Trustee Services Private Limited, a promoter of the company, for a total investment of Rs 6,499,999,819.50. A minimum of Rs 3,250,000,000 will be paid at the time of subscription and allotment, with the remaining consideration due upon exercise of the warrants, and the company will convene an Extraordinary General Meeting on October 22, 2026, to seek shareholder approval for the issuance.

Aequs Limited has informed the National Stock Exchange of India Limited and BSE Limited that the trading window for dealing in the company's securities will be closed for designated persons and their immediate relatives from October 1, 2026, until 48 hours after the announcement of the unaudited financial results for the quarter ending September 30, 2026.

Aequs Limited will hold a meeting of its Board of Directors on Friday, September 25, 2026, to consider and evaluate a proposal for a preferential issue of warrants convertible into equity shares to the promoter, in one or more tranches, subject to shareholder approval and other statutory requirements.

Aequs Limited’s Nomination and Remuneration Committee approved the grant of 350,000 employee stock options under the Aequs Employee Stock Option Plan 2025, to be issued on August 31, 2026, according to a regulatory filing with the National Stock Exchange of India Limited and BSE Limited. The exercise price for the options is Rs 246 per stock option, which represents the last traded price of Aequs Limited equity shares on the National Stock Exchange of India Limited as of August 28, 2026.

Aequs Limited announced that its board approved the appointment of Ms. Reenah Simon Joseph as Chief Financial Officer (CFO) and Key Managerial Personnel (KMP), effective August 31, 2026. Ms. Joseph most recently served as Deputy Group CFO and Head of Corporate Finance, M & A and Investor Relations at PDS Limited and previously held roles at Future Group and Credit Suisse Securities.

Aequs Limited said its board approved the appointment of M/s. BMP & Co. LLP as Secretarial Auditors for five consecutive years starting from fiscal year 2026-27 to fiscal year 2030-2031, subject to shareholder approval, and the re-appointment of Mr. Rajeev Kaul as Director at the company’s upcoming Annual General Meeting.

Aequs Limited, formerly Aequs Private Limited, announced that its board approved alterations to Clause III(A) of its Memorandum of Association to align its main objects with the business proposed under a scheme of amalgamation with Aerostructures Manufacturing India Private Limited, Aequs Engineered Plastics Private Limited, and Aequs Force Consumer Products Private Limited, following shareholder approval via postal ballot. The alterations include the addition of clauses related to manufacturing polythene, polypropylene, consumer products, precision equipment, and healthcare instruments.

A Monitoring Agency report indicates Aequs Limited has utilized Rs 46.22 crore of the proceeds from its IPO for general corporate purposes, including rent, employee expenses, and investments in subsidiaries like Aequs Force Consumer Products and Aequs Engineered Plastics. While most commitments outlined in the offer document have been completed, some capital expenditure and inorganic growth initiatives face delays with completion dates extending into FY27. A significant balance of Rs 101.57 crore remains unutilized, with Rs 20.56 crore designated for offer expenses and Rs 7.69 crore for OFS-related expenses. The report, based on information from Aequs management and Guru & Jana LLP, notes that the extent of the delays is unascertainable and includes disclaimers regarding the Monitoring Agency’s reliance on provided data and potential commercial relationships with Aequs.